4-CARBAMOYL-1,3-BIS-(2,3,4-TRI-O-ACETYL-BETA-D-RIBOPYRANOSYL)-IMIDAZOLIUM-5-OLATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 5n4hhGRLleC |
|---|---|
| InChI | InChI=1S/C26H33N3O16/c1-10(30)40-16-7-38-25(21(44-14(5)34)19(16)42-12(3)32)28-9-29(24(37)18(28)23(27)36)26-22(45-15(6)35)20(43-13(4)33)17(8-39-26)41-11(2)31/h9,16-17,19-22,25-26H,7-8H2,1-6H3,(H2-,27,36,37)/t16-,17-,19-,20-,21-,22-,25-,26-/m0/s1 |
| InChIKey | RTMVVDYEHKHXHU-DQASMHAKSA-N |
| Mol Weight | 643.6 g/mol |
| Molecular Formula | C26H33N3O16 |
| Exact Mass | 643.186082 g/mol |
| Enantiomer InChIKey | RTMVVDYEHKHXHU-DOBJAXHNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
6-Chloro-2-(N'-methyl-2'-pyrrolyl)-9.beta.-(2',3',5'-tri-O-acetyl)-D,ribo-furanosylpurine
trans-Clausevatine-F
CLAUSEVATINE-E
Inosine, 1-(acetyloxy)-, 2',3',5'-triacetate
Methyl (4R,5S,7R,8R,9S)-8,9-Isopropylidenedioxy-2-benzyl-7-[(methoxymethoxy)methyl]-1,6-dioxa-2-azaspiro[4.4]nonane-4-carboxylate
Methyl (4S,5S,7R,8R,9S)-8,9-Isopropylidenedioxy-2-benzyl-7-[(methoxymethoxy)methyl]-1,6-dioxa-2-azaspiro[4.4]nonane-4-carboxylate
Methyl 2-(acetylamino)-3-[2-(6-ethyl-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-1H-indol-3-yl]propanoate
SPURSEBYIIJLOR-UHFFFAOYSA-N
4H-pyrazolo[3,4-d]pyrimidin-4-one, 5-(3-fluoro-4-methylphenyl)-6-(2-furanyl)-1,5-dihydro-1-(2-methylphenyl)-
2-Amino-1-(dimethylamino)-4-(3-methoxy-4-phenylmethoxyphenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-quinoline-3-carbonitrile
| Title | Journal or Book | Year |
|---|---|---|
| Studies on imidazole derivatives and related compounds.3. Regioselective glycosylation of 4-carbamoylimidazolium-5-olate | Journal of Heterocyclic Chemistry | 1984 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.